| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51K | +239.1% | +2.3% |
| Cost of Revenue | $41K | +4.7% | -45.1% |
| Gross Profit | $11K | +145.1% | +144.7% |
| R&D Expense | $54K | +0.2% | -75.4% |
| SG&A Expense | $369K | -19.8% | -50.2% |
| Operating Income | -$399K | +30.2% | +70.0% |
| Interest Expense | $2K | +1.1% | +201.3% |
| Net Income | -$1.9M | +34.1% | -42.1% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4K | +1333.6% | +233.6% |
| Accounts Receivable | $19K | +1836.9% | -61.4% |
| Current Assets | $29K | +457.6% | -86.4% |
| Total Assets | $52K | -67.6% | -89.5% |
| Current Liabilities | $7.1M | +20.5% | +205.8% |
| Stockholders' Equity | -$7.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$653K | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | $917 | — | — |
| Financing Cash Flow | $656K | — | — |
| Free Cash Flow | -$656K | — | — |
| -262.4% |